NextCure Inc Sustainability Reports
NextCure, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing next-generation immunotherapies for cancer and other immune-related diseases. The company utilizes its proprietary FIND-IO technology platform to identify novel molecular targets and develop first-in-class antibody therapies.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300Y5PR6RJR1STI24
1 reports from 2024 to 2024
Company Profile
NextCure, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing next-generation immunotherapies for cancer and other immune-related diseases. The company utilizes its proprietary FIND-IO technology platform to identify novel molecular targets and develop first-in-class antibody therapies.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
